Alzheimer s Research & TherapyNeurosciencePeer-reviewed journal article
Neuronal overexpression of Nrf2 reduces dystrophic neurites in 5XFAD Alzheimer's disease model mice
Katherine R. SadleiriD, Karen P Gomez, Sidhanth ChandraiD, Makenna L. LeyiD, Ammaarah W. Khatri, Joanna Guo, Yunlu XueiD, Constance L. CepkoiD, Robert J. VassariD
Abstract
BackgroundThe hallmark lesions of the Alzheimers disease (AD) brain are amyloid plaques consisting of the {beta}-amyloid protein and neurofibrillary tangles comprised of hyperphosphorylated, aggregated tau protein, which both cause neuronal dysfunction and loss. One goal of neuroprotective therapies is to maintain normal neuronal function and survival in the presence of toxic pathologies such as plaques and tangles. A potential neuroprotective target is nuclear factor erythroid 2-related factor 2 (Nrf2) transcription factor, which regulates the expression of many antioxidant and detoxification genes. Nrf2 mRNA is decreased in AD brains, and deletion of the Nrf2 gene causes increased BACE1 and A{beta} production and worsened cognitive deficits in amyloid pathology mouse models. Overexpression of Nrf2 in astrocytes has been shown to be protective against neurodegeneration, but the role of Nrf2 is neurons is unclear. MethodsWe overexpressed Nrf2 from birth in neurons of 5XFAD amyloid pathology model mice using AAV8, hypothesizing that neuronal Nrf2 overexpression decreases cortical neuron loss and reduces plaque load by decreasing BACE1 levels. We quantified protein levels by immunoblot and neuropathology by immunofluorescent staining, using two-way ANOVA to measure differences between genotypes and AAV treatments. To assess genetic changes, we performed bulk mRNA seq. ResultsWhile neuronal overexpression of Nrf2 in 5XFAD mice did not prevent neuronal loss as measured by NeuN labeling, decrease neuroinflammation by Iba1 or GFAP labeling, or reduce amyloid load by A{beta} antibody or methoxy-XO4 staining, we show that increased Nrf2 expression reduces BACE1 protein levels, especially in swollen axonal dystrophic neurites around amyloid plaques. Other proteins that accumulate in dystrophic neurites were also reduced, indicating decreased dystrophic neurites overall. Immunoblot analysis suggested increased autophagy was unlikely to play a role, while bulk mRNA sequencing indicated changes in lipid metabolism and microtubule stability may have contributed to reduced dystrophic neurite formation. ConclusionsDystrophic neurites impair action potential conductance and contribute to tau seeding and spreading. Their reduction by neuronal Nrf2 overexpression may protect neurons against these pathologic changes. Further study of the mechanisms by which Nrf2 reduces dystrophic neurites may lead to therapeutic strategies that can limit neuritic damage caused by cerebral amyloid accumulation.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 37th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NRF2 deficiency promotes ferroptosis of astrocytes mediated by oxidative stress in Alzheimer's disease
Zhi Tang, Zhuyi Chen, … Xiaolan Qi·Molecular NeurobiologyPeer-reviewed·Feb 24, 2024
- Ngfr suppresses Lcn2/Slc22a17 signaling, induces neurogenesis and reduces amyloid pathology in the hippocampus of APP/PS1dE9 mouse
Tohid Siddiqui, Mehmet İlyas Coşacak, … Çağhan Kızıl·npj Regenerative MedicinePeer-reviewed·Jul 10, 2023
- Neurotrophic Factor-α1/carboxypeptidase E regulates critical protein networks to rescue neurodegeneration, defective synaptogenesis and impaired autophagy in Alzheimer's Disease mice
Lan Xiao, Pranav Sharma, … Y. Peng Loh·Translational NeurodegenerationPeer-reviewed·Nov 26, 2025
- Noradrenergic signaling controls Alzheimer's disease pathology via activation of microglial β2 adrenergic receptors
Linh Le, Alexis M. Feidler, … Ania Katarzyna Majewska·bioRxiv·Dec 1, 2023
- Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer's Disease
Rikesh M. Rajani, Robert A. Ellingford, … Marc Aurel Busche·PLoS BiologyPeer-reviewed·Jul 23, 2024
- p75 neurotrophin receptor signaling through the RhoA/ROCK pathway contributes to Alzheimers Disease tauopathy
Kang Liao, Meng Xie, Carlos F. Ibáñez·bioRxiv·Feb 23, 2026